Telo Genomics Corp.
TDSGF
$0.07
$0.0057.69%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 105.06% | 1.76% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 29.74% | 12.31% | |||
| Operating Income | -29.74% | -12.31% | |||
| Income Before Tax | -34.21% | -8.27% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -34.21% | -8.27% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -34.21% | -8.27% | |||
| EBIT | -29.74% | -12.31% | |||
| EBITDA | -29.96% | -12.83% | |||
| EPS Basic | -3.51% | -5.56% | |||
| Normalized Basic EPS | -2.78% | -5.88% | |||
| EPS Diluted | 1.41% | 2.74% | |||
| Normalized Diluted EPS | -2.78% | -5.88% | |||
| Average Basic Shares Outstanding | 30.28% | 2.97% | |||
| Average Diluted Shares Outstanding | 30.28% | 2.97% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||